Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Cancer Research and Treatment|September 4, 2025
Long-Term Prognostic Value and Analytical Parameters of the Next-Generation Sequencing-Based Multigene Assay in Hormone Receptor-Positive, HER2-Negative Breast CancerHyunji Kim, Jiwon Koh, Hyunwoo Lee, et al.
Scientific Reports|January 15, 2021
S100A8/A9 mediate the reprograming of normal mammary epithelial cells induced by dynamic cell-cell interactions with adjacent breast cancer cellsSeol Hwa Jo, Woo Hang Heo, Hye-Youn Son, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
Development and Validation of a Next-Generation Sequencing-Based Multigene Assay to Predict the Prognosis of Estrogen Receptor-Positive, HER2-Negative Breast CancerHan-Byoel Lee, Sae Byul Lee, Minsu Kim, et al.
Breast Cancer Research and Treatment|January 14, 2017
Recurrence outcomes after omission of postoperative radiotherapy following breast-conserving surgery for ductal carcinoma in situ of the breast: a multicenter, retrospective study in Korea (KROG 16-02)Kyubo Kim, So-Youn Jung, Kyung Hwan Shin, et al.
BMJ Open|April 20, 2024
Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT projectShelley Potter, Kerry Avery, Rosina Ahmed, et al.
Journal of Breast Cancer|January 3, 2022
A Randomized Controlled Trial for Doing vs. Omitting Intraoperative Frozen Section Biopsy for Resection Margin Status in Selected Patients Undergoing Breast-Conserving Surgery (OFF-MAP Trial)Tae-Kyung Yoo, Young-Joon Kang, Joon Jeong, et al.
Molecular Cancer Research : MCR|April 11, 2023
Triple-Negative Breast Cancer-Derived Extracellular Vesicles Promote a Hepatic Premetastatic Niche via a Cascade of Microenvironment RemodelingWoohang Heo, Woochan Lee, Jong Ho Cheun, et al.
British Journal of Cancer|July 12, 2019
Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I-III breast cancer patientsDae-Won Lee, Han Suk Ryu, Min-Sun Jin, et al.
Annals of Surgical Oncology|November 14, 2025
Germline BRCA1/2 Mutation Prevalence in Unselected ER-Low/HER2-Negative Breast CancerJi Won Yoo, Jinyoung Byeon, Woong Ki Park, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 17, 2021
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancerSoma Saeidi, Su-Jung Kim, Yanymee N Guillen-Quispe, et al.
Pageof 14